Acyclovir

NDC 50268-062 · AvPAK

Generic nameAcyclovir

Dosage formTABLET

RouteORAL

Active ingredient(s)ACYCLOVIR

Strength800 mg/1

Pharmacologic classDNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]

Marketing categoryANDA

Packages

50268-062-15 — 50 BLISTER PACK in 1 BOTTLE, UNIT-DOSE (50268-062-15) / 1 TABLET in 1 BLISTER PACK (50268-062-11)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

50090-5610 — Acyclovir, 50090-6335 — Acyclovir, 50090-6561 — acyclovir, 50090-6578 — Acyclovir, 50090-6844 — Acyclovir, 50090-7216 — acyclovir, 50090-7275 — Acyclovir, 50090-7276 — Acyclovir, 50090-7277 — Acyclovir, 50268-061 — Acyclovir, 51407-145 — Acyclovir, 51407-146 — Acyclovir, 51407-852 — Acyclovir, 51655-300 — Acyclovir, 51655-679 — Acyclovir, 51655-965 — acyclovir, 51672-1360 — Acyclovir, 51672-1361 — Acyclovir, 54348-624 — ACYCLOVIR, 54348-627 — Acyclovir, +172 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels